Appendices Appendices

Cumulative indices for 2009

Author Index Chalmers LJ Friedman JH A 6(1), 83–91 6(2), 249–258 Abdelhafiz AH Chang V Fullhase C 6(4), 515–529 6(2), 249–258 6(2), 177–184 Acsadi G Chanoine JP G 6(1), 41–50 6(1), 23–30 Garske T Ammoury RF Chertin B 6(6), 839–841 6(2), 231–237 6(2), 151–155 Gecse K Arslan G 6(2), 157–164 6(4), 603–613 6(5), 727–732 Chishti A Gibbons MA Artés M 6(1), 51–63 6(6), 805–820 6(3), 407–415 Christrup LL Goldman HB Atala A 6(5), 695–706 6(2), 139–141 6(2), 177–184 Chu LF Golomb J B 6(5), 637–640 6(2), 151–155 Barnes PJ Clark JD 6(2), 157–164 6(6), 769–770 6(5), 637–640 Gourley GR 6(6), 795–804 Cosío PG 6(1), 75–81 Basu S 6(6), 771–773 Greidinger EL 6(4), 459–461 Cote CG 6(3), 433–442 Best C 6(6), 771–773 Grider JS 6(1), 75–81 Cripe TP 6(5), 653–656 Bhosle J 6(3), 297–299 Grove D 6(4), 553–568 Czuczman MS 6(6), 779–782 Birenbaum DS 6(3), 371–380 Gulley JL 6(4), 615–618 D 6(3), 305–308 Birns J Dahan A Gupta SK 6(5), 733–745 6(5), 633–635 6(2), 231–237 Bland RM Dahshan A H 6(1), 11–13 6(1), 83–91 Haberal M Blondeau JM Davis MP 6(5), 727–732 6(6), 851–870 6(5), 645–648 Hall PS Bogarin R Deem S 6(4), 553–568 6(1), 23–30 6(3), 427–432 Heise T Bologna R Denktas AE 6(2), 209–229 6(2), 133–134 6(3), 383–385 Ho D 6(2), 145–149 de Torres JP 6(1), 99–103 6(2), 165–175 6(6), 821–830 Hosoda N Braun MS Dieter RS 6(4), 589–593 6(2), 239–248 6(3), 427–432 Hung WH Brookoff D Dinis J 6(6), 775–777 6(5), 649–651 6(4), 595–602 I Brown SHM Djedid R Ilany J 6(4), 515–529 6(3), 351–370 6(4), 455–457 Burke TA E Ingber M 6(4), 595–602 Eisen T 6(2), 143–144 Bush A 6(1), 111–124 Irons BK 6(1), 31–39 Elez E 6(4), 469–473 C 6(3), 321–333 Ishii M Cameron AJ F 6(4), 589–593 6(4), 489–496 Farbstein D Ison MG Cameron DA 6(4), 531–538 6(6), 883–891 6(4), 553–568 Feinstein JA Iwasaki T Capdevila J 6(4), 541–543 6(4), 589–593 6(3), 321–333 Feldman TL Izquierdo I Cappuzzo F 6(1), 15–22 6(3), 417–425 6(3), 335–350 Flomenhoft J Casanova C 6(1), 65–75 Jiang H 6(6), 771–773 Fonseca VA 6(1), 41–50 Celli BR 6(4), 475–487 Jurkiewicz D 6(6), 769–770 Fortea J 6(3), 417–425 6(6), 771–773 6(3), 407–415 K Cerone J Kalra L 6(2), 145–149 6(5), 733–745

future science group www.futuremedicine.com 905 Appendices Appendices

Kamrava M Moray G Shantsila E 6(3), 305–308 6(5), 727–732 6(2), 187–189 Karakayali H Moreira A Shaw JE 6(5), 727–732 6(4), 595–602 6(4), 489–496 Khubchandani S Mulligan D Siddique A 6(3), 371–380 6(2), 165–175 6(2), 187–189 Kiessling SJ N Singh R 6(1), 51–63 Nagireddy P 6(4), 507–513 Kim JJ 6(4), 475–487 Sivaswamy 6(3), 309–320 Nanjundappa A 6(1), 41–50 Kirsh KL 6(3), 427–432 Small CB 6(5), 685–693 Newell ML 6(3), 393–406 Kiss R 6(1), 11–13 Smith HS 6(3), 351–370 Nistala R 6(5), 629–631 Klenha K 6(4), 507–513 6(5), 667–683 6(3), 417–425 Nonoda Y 6(5), 685–693 Koepke M 6(4), 589–593 Soler R 6(2), 145–149 Nowak D 6(2), 177–184 Kowalski ML 6(3), 417–425 Sowers JR 6(3), 417–425 P 6(4), 451–453 Kruszewski J Palmer JS Špičaková M 6(3), 417–425 6(2), 131–132 6(3), 417–425 L 6(2), 133–134 Spierings Larenas-Linnemann D Peake MD 6(5), 657–665 6(2), 279–283 6(4), 569–575 Stiegler RS Lefranc F Peer D 6(4), 489–496 6(3), 351–370 6(3), 293–296 Sueblinvong V Levy AP Perez-Garcia J 6(6), 779–782 6(4), 531–538 6(3), 321–333 Surampudi PN Lichtman SM Plazas MJ 6(4), 475–487 6(6), 893–902 6(3), 407–415 Sweetenham JW Lip GYH Polverino F 6(3), 291–292 6(2), 187–189 6(6), 771–773 T Lockley M R Tabernero J 6(1), 111–124 Ramos FJ 6(3), 321–333 Lundorff L 6(3), 321–333 Takei K 6(5), 695–706 Raposo J 6(4), 589–593 M 6(4), 595–602 Tan T Ma L Rennard SI 6(3), 427–432 6(4), 595–602 6(6), 791–793 Teper A Macarulla T Rini BI 6(3), 393–406 6(3), 321–333 6(3), 309–320 Tinmouth A Mahller YY Rixe O 6(5), 747–757 6(3), 297–299 6(3), 305–308 Torgay A Makaryus AN Robak T 6(5), 727–732 6(4), 497–505 6(4), 577–587 Tolia Marsden AL Roger A 6(1), 1–2 6(4), 541–543 6(3), 407–415 6(1), 65–75 McCleane Róka R 6(1), 83–91 6(5), 707–711 6(4), 603–613 Tranexamic acid McFarlane SI Rosh JR 6(5), 747–757 6(4), 451–453 6(1), 15–22 Trivedi S 6(4), 497–505 Rossi 6(3), 433–442 6(4), 507–513 6(1), 95–98 Twelves CJ McIntyre L Ruiz-Echarri M 6(2), 239–248 6(5), 747–757 6(3), 321–333 U Metro G S Umpierrez GE 6(3), 335–350 Schliess F 6(4), 459–461 Miller J 6(2), 209–229 V 6(1), 7–9 Seberová E van Hateren KJJ Mogensen CE 6(3), 417–425 6(5), 715–717 6(4), 467–468 Sethi T Vanderhoven-Augustin IML Mor Y 6(6), 805–820 6(6), 831–835 6(2), 151–155 Sevmis S Vasavada S 6(2), 157–164 6(5), 727–732 6(2), 209–229 Mora S Shashidhar H 6(3), 407–415 6(1), 65–75

906 Therapy (2009) 6(6) future science group Appendices Appendices

Vernerová E Aliskiren Bapineuzumab 6(3), 417–425 6(4), 497–505 6(2), 259–277 Vilsbøll T 6(5), 719–725 Batimastat 6(2), 199–207 6(6), 805–820 W 6(4), 603–613 Beclomethasone dipropionate Weil AJ Alvimopan 6(3), 393–406 6(6), 871–881 6(4), 603–613 Bendamustine Weiss DJ 6(5), 657–665 6(4), 577–587 6(6), 779–782 6(5), 667–683 Benztropine Werner M Amantadine 6(2), 249–258 6(5), 695–706 6(6), 883–891 Bevacimab Wesseling G Amikacin 6(3), 309–320 6(6), 787–790 6(6), 851–870 Bevacizumab Whaley-Connell A Amiloride 6(1), 111–124 6(4), 507–513 6(1), 51–63 6(2), 239–248 Wisniewski T Aminocaproic acid 6(3), 305–308 6(4), 595–602 6(5), 747–757 6(3), 309–320 Wisnivesky JP Aminoglycoside 6(3), 321–333 6(6), 775–777 6(6), 851–870 6(3), 335–350 Wittmann T Amitriptyline 6(3), 351–370 6(4), 603–613 6(5), 667–683 6(6), 805–820 Wouters EFM 6(6), 871–881 Bexarotene 6(6), 831–835 Amlodipine 6(3), 371–380 Y 6(4), 515–529 Bexxar Yeter E Amoxicillin 6(3), 371–380 6(3), 383–385 6(1), 65–75 Bevacizumab Z 6(2), 145–149 6(5), 719–725 Zietkowski Z 6(3), 393–406 Bleomycin 6(3), 417–425 Ampicillin 6(4), 595–602 Zimmet PZ 6(2), 145–149 Blondeau JM 6(4), 489–496 6(6), 851–870 6(6), 851–870 AN1792 BMS-275291 Compound Index 6(2), 259–277 6(6), 805–820 5-fluorouracil Anthracycline Bosentan 6(2), 239–248 6(4), 553–568 6(5), 719–725 6(3), 305–308 Apixaban Bosutinib 6(3), 321–333 6(2), 187–189 6(3), 321–333 A Aprotinin Bortezomib A-32278 6(5), 747–757 6(3), 351–370 6(6), 883–891 6(6), 883–891 Botulinum A toxin Ab42 Aripiprazole 6(2), 131–132 6(2), 259–277 6(2), 249–258 6(2), 133–134 Abciximab Asimadoline 6(2), 143–144 6(3), 383–385 6(4), 603–613 6(2), 157–164 Acetaminophen 6(5), 667–683 Botulinum toxin 6(5), 645–648 Aspart 6(2), 139–141 6(5), 667–683 6(2), 209–229 6(2), 133–134 6(5), 695–706 Aspirin 6(2), 177–184 Aclidinium 6(2), 187–189 6(6), 795–804 Atenolol 6(1), 31–39 Acyclovir 6(1), 51–63 6(2), 231–237 6(5), 719–725 6(4), 515–529 6(3), 393–406 ADL 10–0101 Atorvastatin Buprenorphine 6(5), 667–683 6(2), 259–277 6(5), 695–706 ADZ8309 6(4), 475–487 6(5), 637–640 6(6), 795–804 6(4), 515–529 6(5), 707–711 Adriamycin Axitinib 6(5), 645–648 6(3), 371–380 6(1), 111–124 6(5), 649–651 6(4), 595–602 6(3), 309–320 C Albuterol Azalastin Calderol 6(5), 653–656 6(2), 279–283 6(1), 75–81 Alemtuzumab Aztreonam Camptosar 6(3), 371–380 6(6), 851–870 6(2), 239–248 6(4), RUBAK B Canakinumab Alfentanil Baclofen 6(5), 719–725 6(5), 633–635 6(5), 667–683

future science group www.futuremedicine.com 907 Appendices Appendices

Capecitabine Cisplatin Dalbavancin 6(2), 239–248 6(3), 335–350 6(6), 851–870 6(3), 305–308 6(3), 371–380 Daptomycin 6(3), 321–333 6(4), 569–575 6(6), 851–870 6(4), 553–568 Citalopram Darifenacin 6(4), 569–575 6(4), 603–613 6(2), 157–164 Captopril Cladribine DAS181 6(4), 497–505 6(4), 577–587 6(6), 883–891 6(4), 515–529 Clarithromycin Dasatinib Carbamazepine 6(1), 65–75 6(3), 351–370 6(1), 41–50 6(2), 279–283 6(3), 321–333 Carbapenem Clavulanate potassium Daunorubicin 6(6), 851–870 6(3), 393–406 6(4), 569–575 Carboplatin Clavularate Deflux 6(3), 335–350 6(2), 145–149 6(2), 157–164 6(3), 371–380 Clemastine Deferolimus 6(4), 569–575 6(3), 417–425 6(3), 321–333 6(4), 595–602 Clioquinol Denileukin diftitox Carisoprodol 6(2), 259–277 6(3), 371–380 6(6), 871–881 Clobazam Dexamethasone Carmustine 6(4), 589–593 6(3), 371–380 6(3), 351–370 Clofibrate 6(4), 595–602 6(3), 371–380 6(6), 795–804 6(5), 719–725 CDX-110 Clonidin Dextofisopam 6(3), 351–370 6(4), 603–613 6(4), 603–613 Cediranib 6(5), 637–640 Diclofenac 6(3), 309–320 6(5), 667–683 6(2), 259–277 6(3), 321–333 Clopidogrel 6(5), 719–725 6(3), 351–370 6(2), 187–189 Diltiazem Cefepime Clozapine 6(4), 497–505 6(6), 851–870 6(2), 249–258 Dimebon Celecoxib Cocaine 6(2), 259–277 6(2), 239–248 6(5), 637–640 Dimethyl sulfoxide 6(2), 259–277 6(5), 685–693 6(2), 133–134 Certican® Codeine Diphenhydramine 6(3), 351–370 6(5), 633–635 6(6), 871–881 Cetilistat 6(5), 707–711 Ditropan 6(1), 23–30 6(5), 719–725 6(2), 157–164 Cetuximab 6(5), 667–683 6(2), 239–248 Colesevelam 6(5), 657–665 6(3), 335–350 6(4), 475–487 Donepezil 6(3), 305–308 Colistin 6(2), 259–277 6(3), 321–333 6(6), 851–870 Doripenem Chloramphenicol Colostrinin 6(6), 851–870 6(6), 851–870 6(2), 259–277 Doxazosin Chlorpromazine Corticosteroid 6(1), 51–63 6(2), 249–258 6(1), 31–39 6(4), 497–505 Chlorpropamide Cromolyn sodium Doxorubicin 6(4), 507–513 6(2), 231–237 6(4), 569–575 Chlorthalidone CS8959 6(4), 595–602 6(4), 515–529 6(6), 883–891 Drisdol Chlorzoxazone Cyanovirin-N 6(1), 75–81 6(6), 871–881 6(6), 883–891 Dronabinol Cholestyramine Cyclobenzaprine 6(5), 667–683 6(1), 75–81 6(6), 871–881 Dronedarone Cyclophosphamide 6(5), 719–725 6(4), 603–613 6(1), 99–103 Duloxetine Cilastatin 6(3), 371–380 6(4), 603–613 6(6), 851–870 6(4), 577–587 Dysport® Cilengitide 6(4), 595–602 6(2), 165–175 6(3), 351–370 Cytarabine E 6(3), 371–380 Ebastine 6(4), 603–613 D 6(3), 407–415 Ciprofloxacin Dabigatran EGb 761 6(6), 851–870 6(2), 187–189 6(2), 259–277 Dacarbazine Eloxatin 6(5), 657–665 6(4), 595–602 6(2), 239–248

908 Therapy (2009) 6(6) future science group Appendices Appendices

EM-703 Fluoropyrimidine Hydrocodone 6(6), 795–804 6(3), 321–333 6(5), 645–648 Enadoline Fluoroquinolone Hydrocortisone 6(5), 667–683 6(6), 851–870 6(5), 719–725 Enalapril Fluoxetine Hydromorphone 6(1), 51–63 6(4), 603–613 6(5), 629–631 Enoxaparin Fluphenazine 6(5), 641–644 6(2), 187–189 6(2), 249–258 6(5), 653–656 Enzastaurin Flurbiprofen 6(5), 695–706 6(3), 351–370 6(2), 259–277 Hydroxychloroquine Epirubicin Fluticasone 6(2), 259–277 6(4), 595–602 6(2), 231–237 Hydrochlorothiazide Eptratuzumab 6(3), 393–406 6(5), 719–725 6(3), 371–380 Fluticasone furoate I Erlotinib 6(3), 393–406 Ibritumomab 6(1), 51–63 6(3), 371–380 6(1), 95–98 6(3), 393–406 6(3), 321–333 Folate/B6/B12 6(5), 667–683 6(3), 335–350 6(2), 259–277 Ibuprofen 6(3), 351–370 Folinic acid 6(5), 719–725 6(4), 569–575 6(3), 305–308 Ifosfamide Erythropoietin Fostamatinib disodium 6(3), 371–380 6(5), 747–757 6(3), 371–380 Iloprost Etanercept G 6(5), 719–725 6(2), 259–277 Galantamine Imatinib Etoposide 6(2), 259–277 6(3), 291–292 6(3), 371–380 Galimberti D 6(3), 309–320 6(3), 351–370 6(2), 259–277 6(3), 351–370 Everolimus Gabapentin Imipenem 6(3), 309–320 6(5), 667–683 6(6), 851–870 6(3), 321–333 Gatifloxacin Imipramine 6(3), 351–370 6(6), 851–870 6(6), 871–881 6(3), 371–380 Gefitinib 6(5), 719–725 6(1), 95–98 6(6), 795–804 Ezitemide 6(3), 309–320 Indapamide 6(4), 475–487 6(3), 321–333 694), 515–529 F 6(3), 335–350 Indomethacin FE 200665 6(3), 351–370 6(2), 259–277 6(5), 667–683 6(4), 569–575 Infliximab FE 200666 6(5), 719–725 6(1), 15–22 6(5), 667–683 Gemcitabine 6(6), 795–804 Fedotozine 6(3), 335–350 Insulin glulisine 6(4), 603–613 6(4), 569–575 6(2), 209–229 Felodepine 6(6), 893–902 Irbesartan 6(4), 515–529 Gentamicin 6(1), 51–63 Fenofibrate 6(6), 851–870 Irinotecan 6(4), 469–473 Gliclazide 6(2), 239–248 6(4), 475–487 6(4), 507–513 6(3), 305–308 Fentanyl Glimepiride 6(3), 321–333 6(5), 629–631 6(2), 199–207 6(3), 351–370 6(5), 633–635 Glipizide 6(4), 569–575 6(5), 641–644 6(5), 653–656 Isotretinoin 6(5), 645–648 Granisetron 6(3), 351–370 6(5), 653–656 6(4), 595–602 K 6(5), 695–706 GSK-961081 Ketamine 6(5), 707–711 6(6), 795–804 6(5), 645–648 6(5), 719–725 H Ketorolac tromethamine Ferumoxytol Haloperidol 6(5), 719–725 6(5), 719–725 6(2), 249–258 L Fludarabine Heroin Labetalol 6(4), 577–587 6(5), 685–693 6(1), 51–63 6(5), 667–683 Lamotrigine 6(3), 393–406 Huperizine A 6(1), 41–50 Fluorouracil 6(2), 259–277 Lapatinib 6(1), 99–103 Hydralazine 6(3), 351–370 6(4), 595–602 6(1), 51–63 6(4), 553–568

future science group www.futuremedicine.com 909 Appendices Appendices

Leucovorin Metastat N 6(2), 239–248 6(3), 351–370 N-acetyldinaline 6(3), 305–308 Metaxalone 6(6), 805–820 6(3), 321–333 6(6), 871–881 Naloxone Levomethadone Metformin 6(5), 637–640 6(5), 633–635 6(1), 23–30 6(5), 667–683 Levetiracetam 6(2), 199–207 Naltrexone 6(1), 41–50 6(4), 475–487 6(5), 667–683 Lenalidomide 6(4), 489–496 Naltrindole 6(3), 371–380 6(4), 507–513 6(5), 667–683 Levof loxacin, 6(4), 515–529 Naproxene 6(6), 851–870 6(4), 531–538 6(2), 259–277 Levorphanol Methadone Nateglinide 6(5), 645–648 6(5), 637–640 6(4), 507–513 Linaclotide 6(5), 641–644 Neomycin 6(4), 603–613 6(5), 645–648 6(4), 603–613 Linezolid 6(5), 649–651 Nepadutant 6(6), 851–870 6(5), 657–665 6(4), 603–613 Liraglutide 6(5), 695–706 Neutral protamine hagedorn 6(2), 199–207 6(5), 707–711 6(2), 209–229 6(5), 719–725 Methotrexate Nevirapine Lisinopril 6(1), 99–103 6(1), 11–13 6(1), 51–63 6(4), 569–575 Nexavar® 6(4), 515–529 Methylnaltrexone see Sorafenib Lispro 6(4), 603–613 Nicardipine 6(2), 259–277 6(5), 657–665 6(1), 51–63 Lonafarnib 6(5), 667–683 Nifedipine 6(3), 351–370 Metoprolol 6(1), 51–63 Loratadine 6(1), 51–63 Nimesulide 6(3), 417–425 Metronidazole 6(2), 259–277 Lorazepam 6(1), 65–75 Nimutuzumab 6(5), 667–683 6(6), 851–870 6(3), 351–370 Losartan Minocycline Nitrazepam 6(1), 51–63 6(6), 851–870 6(4), 589–593 6(4), 497–505 Mirtazapine Nitrendipine 6(4), 515–529 6(5), 719–725 6(4), 515–529 Lovastatin Misoprostol Nitroprusside 6(4), 475–487 6(5), 657–665 6(1), 51–63 Lubiprostone Mitiglinide Nor-binaltorphimine 6(4), 603–613 6(4), 507–513 6(5), 667–683 Lubiprostone Mitomycin Norfloxcine 6(5), 657–665 6(3), 321–333 6(2), 145–149 LY450139 Mitoquinone 6(2), 259–277 6(2), 259–277 O M Mitoxantrone Oxacillin Maraviroc 6(6), 893–902 6(6), 851–870 6(6), 795–804 Mizolastine Octylonium bromide Marimastat 6(3), 417–425 6(4), 603–613 6(3), 351–370 furoate Ofatumumab 6(6), 795–804 6(3), 393–406 6(4), 577–587 6(6), 805–820 6(5), 719–725 Olanzapine Morphine 6(2), 249–258 6(4), 603–613 6(5), 629–631 Melphalan 6(5), 633–635 6(2), 279–283 6(3), 371–380 6(5), 637–640 ONO-4817 Memantine 6(5), 641–644 6(6), 805–820 6(2), 259–277 6(5), 645–648 Ondansetron Mephenesin 6(5), 653–656 6(4), 595–602 6(6), 871–881 6(5), 657–665 6(5), 637–640 Mepolizumab 6(5), 667–683 Orlistat 6(2), 231–237 6(5), 695–706 6(1), 23–30 Meropenem 6(5), 707–711 Orphenadrine citrate 6(6), 851–870 Morphine-6-glucuronide 6(6), 871–881 Methocarbamol 6(5), 633–635 Oseltamivir 6(6), 871–881 6(5), 667–683 6(6), 883–891 Mupirocin 6(5), 657–665 6(2), 279–283

910 Therapy (2009) 6(6) future science group Appendices Appendices

Oxaliplatin Pitavastatin Rifaximin 6(2), 239–248 6(5), 719–725 6(4), 603–613 6(3), 305–308 Pioglitazone Rimantadine 6(3), 321–333 6(4), 507–513 6(6), 883–891 Oxcarbazepine 6(4), 515–529 Risperidone 6(1), 41–50 6(4), 531–538 6(2), 249–258 Oxybutynin Poly-l-lactic acid Rituximab 6(2), 157–164 6(5), 719–725 6(3), 291–292 6(5), 653–656 Polymyxin 6(3), 371–380 Oxycodone 6(6), 851–870 6(4), 577–587 6(5), 633–635 Prasugrel Rivaroxaban 6(5), 641–644 6(5), 719–725 6(2), 187–189 6(5), 653–656 Prazosin Rivastigmine 6(5), 657–665 6(1), 51–63 6(2), 259–277 6(5), 667–683 6(5), 653–656 Rofecoxib 6(5), 695–706 Prednisolone 6(2), 259–277 6(5), 707–711 6(1), 31–39 Oxymorphone Prednisone 6(6), 795–804 6(5), 653–656 6(3), 371–380 6(6), 787–790 P 6(4), 595–602 Rosiglitazione Paclitaxel Prinomastat 6(2), 199–207 6(1), 99–103 6(3), 351–370 6(2), 259–277 6(3), 335–350 6(6), 805–820 6(4), 455–457 6(6), 893–902 ProchymalTM 6(4), 507–513 Palanosetron 6(6), 779–782 6(4), 515–529 6(5), 637–640 Propranolol 6(4), 531–538 Paliperidone palmitate 6(1), 51–63 6(6), 795–804 6(5), 719–725 Prourokinase Rouracil Panitumumab 6(5), 733–745 6(3), 321–333 6(1), 111–124 Prucaloprid Rupatadine 6(2), 239–248 6(4), 603–613 6(3), 417–425 6(3), 305–308 Q S 6(3), 321–333 Quetiapine Pazopanib 6(2), 249–258 6(1), 31–39 6(1), 111–124 R 6(3), 309–320 R-118958 6(6), 787–790 6(3), 351–370 6(6), 883–891 Saxagliptin PBT2 Ramipril 6(5), 719–725 6(2), 259–277 6(4), 497–505 Scarpini E Pemetrexed 6(4), 515–529 6(2), 259–277 6(3), 335–350 Ramosetron Scyllo-inositol 6(4), 569–575 6(4), 603–613 6(2), 259–277 6(5), 719–725 Raltegravir SD-282 Penicillin 6(5), 719–725 6(6), 795–804 6(6), 851–870 Rapamycin Semaxanib Pentostatin 6(3), 309–320 6(3), 321–333 6(4), 577–587 6(3), 321–333 Serotonin Peramivir 6(3), 351–370 6(4), 603–613 6(6), 883–891 Reboxetine Sialylglycopolymer Perindopril 6(5), 667–683 6(6), 883–891 6(4), 515–529 Recombinant activated Factor VII Simvastatin Phenobarbital 6(5), 747–757 6(2), 259–277 6(1), 41–50 Recombinant tissue plasminogen activator 6(4), 475–487 6(1), 75–81 6(5), 733–745 Siplizumab 6(4), 589–593 RemberTM 6(3), 371–380 Phenserine 6(2), 259–277 Sirolimus 6(2), 259–277 Renzapride 6(3), 351–370 Phenytoin 6(4), 603–613 Solifenacin 6(1), 41–50 Reserpine 6(2), 157–164 Plerixafor 6(4), 515–529 Sorafenib 6(5), 719–725 Ribavirin 6(1), 51–63 Pimavanserin 6(6), 883–891 6(3), 309–320 6(2), 249–258 Rifampicin 6(3), 321–333 Pinaverimun bromide 6(6), 851–870 6(3), 351–370 6(4), 603–613 Rifampin Sotalol HCl Piperacillin 6(1), 75–81 6(5), 719–725 6(6), 851–870

future science group www.futuremedicine.com 911 Appendices

Sparfloxacin Terfenadine U 6(2), 145–149 6(3), 417–425 Urokinase Spironolactone Teriparatide 6(5), 733–745 6(1), 51–63 6(5), 719–725 Ursodeoxycholic acid 6(4), 497–505 Tetracycline 6(1), 75–81 Streptokinase 6(6), 851–870 V 6(5), 733–745 Tetrahydrocannabinol Valproic acid Sufentanil 6(5), 667–683 6(4), 589–593 6(5), 695–706 Valsartan Sulfamethoxazole 6(6), 795–804 6(1), 51–63 6(2), 145–149 Tigecycline Vancomycin 6(6), 851–870 6(6), 851–870 6(6), 851–870 Sulfonylurea Tiotropium Vandetanib 6(4), 475–487 6(2), 279–283 6(3), 321–333 6(4), 515–529 6(6), 795–804 6(3), 351–370 Sumatriptan 6(6), 787–790 Vatalanib 6(5), 719–725 Tipifarnib 6(3), 321–333 Sunitinib 6(3), 351–370 6(3), 351–370 6(1), 111–124 Tobramycin Verapamil 6(3), 309–320 6(6), 851–870 6(4), 497–505 6(3), 321–333 Tocilizumab 6(5), 653–656 6(3), 351–370 6(6), 795–804 Vigabatrin T Tolazamide 6(1), 41–50 T-705 6(4), 507–513 Vinblastine 6(6), 883–891 Tolbutamide 6(4), 595–602 Tacrolimus 6(4), 507–513 Vincristine 6(5), 719–725 Tolterodine 6(3), 371–380 6(2), 157–164 Vinorelbine 6(4), 603–613 Tolvaptan 6(1), 95–98 Tamoxifen 6(5), 719–725 6(3), 335–350 6(3), 351–370 Topiramate 6(4), 569–575 Tarenflurbil 6(1), 41–50 Viramidine 6(2), 259–277 Torisel® 6(6), 883–891 Tapentadol 6(3), 351–370 Volociximab 6(5), 667–683 Tositumomab 6(3), 309–320 Taxane 6(3), 371–380 Vorinostat 6(3), 335–350 Tramadol 6(3), 351–370 6(4), 553–568 6(5), 633–635 6(6), 805–820 Taxol® 6(5), 667–683 W see Paclitaxel 6(5), 707–711 Warfarin Tazobactam Tramiprosate 6(2), 187–189 6(6), 851–870 6(2), 259–277 6(6), 851–870 Tegaserod Trastuzumab X 6(4), 603–613 6(4), 553–568 Xenical® 6(5), 657–665 Treprostinil see Orlistat Telithromycin 6(5), 719–725 Ximelagatran 6(6), 851–870 acetonide 6(2), 187–189 Telmisartan 6(3), 393–406 XL765 6(4), 497–505 Triamterene 6(3), 351–370 Temsirolimus 6(1), 51–63 Z 6(1), 111–124 Zanamivir 6(3), 351–370 6(4), 603–613 6(6), 883–891 6(3), 371–380 Trimethoprim Zevalin Temozolomide 6(2), 145–149 6(3), 371–380 6(3), 351–370 6(6), 851–870 Zidovudine Temsirolimus Triptorelin 6(1), 11–13 6(3), 309–320 6(5), 719–725 Ziconotide Tenecteplase Troglitazone 6(5), 667–683 6(5), 733–745 6(4), 489–496 Ziprasadone Terazosin 6(6), 795–804 6(2), 249–258 6(1), 51–63 Trospium chloride Zoledronic acid 6(2), 157–164 6(5), 719–725 Zonisanide 6(1), 41–50

912 Therapy (2009) 6(6) future science group